Hospital Acquired Infection Control Market Size & Growth Forecast 2027–2036, By Segments (Type, End Use), Regional Demand Trends (North America, Asia Pacific, Europe), Key Country Insights (U.S., Japan, South Korea, Germany, France, Italy), and Competitive Landscape
Market Size and Growth Outlook
Hospital Acquired Infection Control Market size was around USD 23.7 billion in 2026 and is slated to grow at a 6.37% CAGR from 2027 to 2036, surpassing USD 43.95 billion by 2036. The industry revenue for 2027 is calculated at USD 24.97 billion.
Get more details on this report
Request Free Sample ReportHospital Acquired Infection Control Market Intelligence Snapshot
Regional Market Dynamics
- North America captured a 51.70% market share in 2026, supported by advanced hospital infrastructure, established infection surveillance, strict compliance standards, and consistent investment in infection prevention solutions.
- Asia Pacific is forecast to expand at a 7.57% CAGR as hospital infrastructure grows, standardized infection prevention practices increase, and healthcare facilities strengthen hygiene and sterilization protocols.
Segment Momentum
- Hospitals and ICUs lead the market because high-risk patients, invasive procedures, and continuous care require sustained infection prevention measures, driving consistently high demand for infection control solutions.
- Services are growing fastest as healthcare providers increasingly adopt outsourced sterilization, infection surveillance, training, and compliance support to strengthen infection control without expanding internal operational resources.
Market Expansion Drivers
- Increasing hospital-acquired infection incidence driving urgent prevention and control demand.
- Advanced sterilization and smart surveillance technologies improving infection control efficiency.
- Strengthening healthcare compliance standards enforcing stricter infection prevention protocols.
Leading Market Participants
- Top players in the hospital acquired infection control market include 3M Company (United States), STERIS plc (Ireland), Getinge AB (Sweden), Advanced Sterilization Products, Inc. (United States), Belimed AG (Switzerland), Sotera Health Company (United States), Midmark Corporation (United States), MMM Group (Germany), Owens & Minor, Inc. (United States), W&H Dentalwerk Bürmoos GmbH (Austria).
Global Market Forecast Snapshot
Market Outlook
- 2026 Market Size: USD 23.7 billion
- 2027 Estimated Market Size: USD 24.97 billion.
- Projected Market Size: USD 43.95 billion by 2036
- Growth Forecast: 6.37% CAGR (2027-2036)
Regional and Segment Outlook
- Leading Regional Market: North America
- High-Growth Regional Hub: Asia Pacific
- Core Revenue Segment: Consumables (Type) | Hospitals and Intensive Care Units (ICUs) (End Use)
- Emerging Opportunity Segment: Services (Type) | Ambulatory Surgical and Diagnostic Centres (End Use)
Market Growth Drivers and Industry Trends
Increasing hospital-acquired infection incidence driving urgent prevention and control demand
The hospital acquired infection control market is gaining momentum as rising incidence of infections within healthcare facilities increases the urgency of prevention, monitoring, and containment measures. Healthcare providers are strengthening infection control practices to reduce transmission risks, improve patient safety, and support more consistent implementation of hygiene, disinfection, and environmental control procedures.
Advanced sterilization and smart surveillance technologies improving infection control efficiency
Advanced sterilization solutions and smart surveillance systems are enabling the hospital acquired infection control market to address infection risks with greater efficiency and visibility. Healthcare facilities are adopting technologies that support more effective sterilization, continuous monitoring, and timely identification of potential infection threats, helping infection control teams improve operational oversight and respond more quickly to emerging risks.
Strengthening healthcare compliance standards enforcing stricter infection prevention protocols
Stricter healthcare compliance requirements are supporting the hospital acquired infection control market by encouraging facilities to formalize and reinforce infection prevention protocols. Hospitals are placing greater emphasis on standardized sterilization, monitoring, documentation, and hygiene procedures to maintain compliance and strengthen accountability across clinical and operational environments.
| Growth Driver | Impact on CAGR | Regulatory Influence | Geographic Relevance | Adoption Rate | Impact Timeline |
|---|---|---|---|---|---|
| Increasing hospital-acquired infection incidence driving urgent prevention and control demand | 2.30% | High | North America, Europe, Asia Pacific | High | Near Term |
| Advanced sterilization and smart surveillance technologies improving infection control efficiency | 2.00% | High | North America, Europe | High | Mid Term |
| Strengthening healthcare compliance standards enforcing stricter infection prevention protocols | 1.70% | High | North America, Europe, Asia Pacific | High | Near Term |
Unlock insights tailored to your business with our bespoke market research solutions.
Click to get your customized report now.
Regional Demand Dynamics
North America (Largest Region)
North America dominated the hospital acquired infection control market with a 51.70% share in 2026, supported by well-established healthcare infrastructure, stringent infection prevention practices, and strong emphasis on patient safety. Hospitals and healthcare facilities in the region increasingly prioritize comprehensive infection surveillance, environmental hygiene, sterilization, and antimicrobial management to reduce healthcare-associated risks. Advanced diagnostic capabilities and widespread adoption of standardized infection-control protocols further strengthen demand for specialized solutions. Regulatory scrutiny, quality requirements, and continued investment in healthcare facility modernization also encourage providers to maintain robust infection prevention programs.
Asia Pacific (Fastest-Growing Region)
Asia Pacific is the fastest-growing regional market, driven by expanding healthcare infrastructure, rising patient volumes, and increasing awareness of hospital-acquired infection prevention. Governments and healthcare providers are placing greater emphasis on improving hospital hygiene, sterilization practices, and clinical safety as healthcare systems modernize. Growing investment in hospitals and diagnostic facilities is creating additional demand for infection-control technologies and consumables. At the same time, greater awareness among healthcare professionals regarding antimicrobial resistance and healthcare-associated risks is encouraging more systematic adoption of preventive measures across both established and developing healthcare markets.
| Parameter | North America | Asia Pacific | Europe | Latin America | MEA |
|---|---|---|---|---|---|
| Innovation Hub i Scale Nascent Developing Advanced | |||||
| Cost-Sensitive Region i Scale Low Medium High | |||||
| Regulatory Environment i Scale Restrictive Neutral Supportive | |||||
| Demand Drivers i Scale Weak Moderate Strong | |||||
| Development Stage i Scale Emerging Developing Developed | |||||
| Adoption Rate i Scale Low Medium High | |||||
| New Entrants / Startups i Scale Sparse Moderate Dense | |||||
| Macro Indicators i Scale Weak Stable Strong |
Key Country Insights
Germany 🇩🇪
Sterilization Quality FocusGermany emphasizes reliable sterilization technologies, validated disinfection processes, and rigorous hospital hygiene standards. German healthcare facilities continue investing in automated infection control systems that support operational consistency and regulatory compliance.
France 🇫🇷
Clinical Prevention ProgramsFrance reinforces hospital acquired infection control through coordinated prevention programs, staff training, and standardized hygiene practices. French healthcare institutions continue modernizing disinfection technologies while improving compliance with infection prevention protocols.
Italy 🇮🇹
Hospital Hygiene ModernizationItaly focuses on strengthening hospital hygiene through upgraded sterilization equipment, improved environmental cleaning, and structured infection surveillance. Italian healthcare providers continue enhancing prevention workflows that reduce healthcare-associated infection risks while supporting quality care.
Japan 🇯🇵
Healthcare Hygiene AutomationJapan advances hospital acquired infection control through automated cleaning technologies, advanced sterilization equipment, and disciplined clinical protocols. Hospitals in Japan increasingly adopt digital monitoring tools that strengthen infection prevention across healthcare facilities.
South Korea 🇰🇷
Digital Monitoring AdoptionSouth Korea integrates digital surveillance platforms with infection prevention programs to strengthen hospital safety. Healthcare providers in South Korea continue expanding automated monitoring, rapid response capabilities, and standardized hygiene management across clinical environments.
United States 🇺🇸
Advanced Infection ProtocolsThe U.S. hospital acquired infection control market prioritizes integrated surveillance, rapid diagnostics, and evidence-based prevention strategies. Healthcare providers across the U.S. continue strengthening antimicrobial stewardship and environmental hygiene programs to improve patient safety.
Segment Leadership and Growth Trends
Hospital Acquired Infection Control Market Share (%), by Type, 2026
Go beyond the chart, access full insights & data tables
Request Free Sample ReportType Segment Analysis: Consumables (Largest Segment) vs Services (Fastest-Growing Segment)
The consumables segment held the largest share of the hospital acquired infection control market in 2026, representing 49.69% of the market, driven by the recurring need for products used in infection prevention and control activities. Consumables are integral to routine hygiene, sterilization, disinfection, and protective procedures across healthcare environments, creating consistent demand as facilities maintain stringent infection-control protocols. Increasing emphasis on preventing healthcare-associated infections and maintaining safe clinical environments further reinforces the segment's leading position.
Services are projected to register the fastest growth as healthcare facilities increasingly seek specialized support for implementing, monitoring, and improving infection-control practices. Service-based solutions can help healthcare providers strengthen protocols, assess infection risks, and improve operational compliance without relying solely on internal resources. Greater focus on systematic infection prevention and the need for efficient implementation of control measures are supporting increased demand for specialized services.
End Use Segment Analysis: Hospitals and Intensive Care Units (ICUs) (Largest Segment) vs Ambulatory Surgical and Diagnostic Centres (Fastest-Growing Segment)
Hospitals and intensive care units (ICUs) accounted for the largest share of the hospital acquired infection control market in 2026, reflecting the high concentration of patients, invasive procedures, and complex care activities within these settings. ICUs in particular require rigorous infection-prevention practices because patients may have heightened exposure to healthcare-associated infection risks. The need for continuous hygiene, sterilization, disinfection, and monitoring across hospital environments therefore sustains strong utilization of infection-control solutions.
Ambulatory surgical and diagnostic centres are expected to grow at the fastest rate as healthcare delivery increasingly emphasizes outpatient procedures, shorter stays, and efficient clinical workflows. These facilities require effective infection-control measures to maintain safe environments while managing procedures outside traditional hospital settings. The expansion of outpatient care and increasing attention to infection prevention across decentralized healthcare facilities are strengthening demand within this end-use segment.
| Segment | Sub-Segment | Largest Segment | Fastest Growing |
|---|---|---|---|
| Type | Equipment, Services, Consumables | Consumables | Services |
| End Use | Hospitals and Intensive Care Units (ICUs), Ambulatory Surgical and Diagnostic Centres, Others | Hospitals and Intensive Care Units (ICUs) | Ambulatory Surgical and Diagnostic Centres |
Competitive Landscape and Market Positioning
Major players in the hospital acquired infection control market:
1. 3M Company (United States)
2. STERIS plc (Ireland)
3. Getinge AB (Sweden)
4. Advanced Sterilization Products Inc. (United States)
5. Belimed AG (Switzerland)
6. Sotera Health Company (United States)
7. Midmark Corporation (United States)
8. MMM Group (Germany)
9. Owens & Minor Inc. (United States)
10. W&H Dentalwerk Bürmoos GmbH (Austria)
Infection prevention strategies are becoming more advanced through integrated hygiene monitoring and sterilization technologies. Collaborative healthcare initiatives are strengthening the development of more effective infection control protocols. The hospital acquired infection control market is evolving through innovation aimed at reducing contamination risks and improving patient safety outcomes.
| Company | Market Share | Company Revenue | Revenue CAGR (%) | Product Portfolio | Geographic Presence | Innovation / R&D Focus | Strategic Developments |
|---|---|---|---|---|---|---|---|
| 3M Company (United States) | |||||||
| STERIS plc (Ireland) | |||||||
| Getinge AB (Sweden) | |||||||
| Advanced Sterilization Products Inc. (United States) | |||||||
| Belimed AG (Switzerland) | |||||||
| Sotera Health Company (United States) | |||||||
| Midmark Corporation (United States) | |||||||
| MMM Group (Germany) | |||||||
| Owens & Minor Inc. (United States) | |||||||
| W&H Dentalwerk Bürmoos GmbH (Austria). |
Industry Development/News
| Company Name | Date | Key Development |
|---|---|---|
| Getinge | Jan-25 | Getinge acquired Healthmark Industries, expanding its infection control consumables portfolio and reinforcing its distribution capabilities in the U.S. healthcare market. The acquisition strengthens Getinge’s positioning in sterile processing solutions by integrating complementary product lines used in hospital infection prevention workflows, supporting broader coverage across central sterile supply departments. |
| Midmark Corporation | Jul-24 | Midmark Corporation launched its next-generation M11 and M9 steam sterilizers featuring enhanced durability, usability, and integrated instrument processing and compliance documentation functions. The introduction strengthens hospital sterilization workflows by improving operational efficiency and traceability in infection control processes within clinical and surgical environments. |
| MMM Group | Jun-23 | MMM Group partnered with Southwest Clinic to establish a centralized CSSD/RUMED facility at the Calw clinic site in Germany. The facility consolidates reprocessing of critical medical instruments for multiple clinics, improving sterilization efficiency, compliance control, and centralized infection prevention infrastructure across regional healthcare operations. |
| Sterigenics U.S., LLC | May-22 | Sterigenics U.S., LLC expanded its electron beam (E-beam) sterilization facility in Indiana, increasing capacity for medical and pharmaceutical product sterilization. The expansion strengthens global infection prevention supply chains by enhancing throughput for outsourced sterilization services critical to healthcare and life sciences manufacturing. |
Customize Your Report
Explore examples of how this report can be tailored to different research needs, including custom segments, additional topics or chapters, and related reports. Click a section of the wheel or its numbered marker to explore the available options.
Hospital Acquired Infection Control Market — Custom Segments
| Segment | Sub-Segment |
|---|---|
| Infection Type | Surgical Site Infections, Catheter-Associated Infections, Ventilator-Associated Infections, Central Line-Associated Bloodstream Infections, Other Healthcare-Associated Infections |
| Infection Prevention Stage | Pre-Procedure Prevention, In-Procedure Prevention, Post-Procedure and Ongoing Prevention |
| Deployment Model | Point-of-Care Deployment, Centralized Deployment, Facility-Wide Deployment |
Hospital Acquired Infection Control Market — Custom TOC
| Custom Chapter | Custom Details |
|---|---|
| Hospital Infection Prevention Program Benchmarking |
|
| Antimicrobial Resistance Impact Assessment |
|
| Infection Control Technology Adoption Roadmap |
|
Need a different cut of the data?
Request Custom ResearchHow much revenue does the hospital acquired infection control market generate?
What is the forecasted size of the hospital acquired infection control industry?
How are hospitals changing procurement strategies to strengthen infection prevention?
Why are advanced sterilization and surveillance technologies becoming strategic investments?
Why are Hospitals and Intensive Care Units (ICUs) the largest end-use segment in the hospital acquired infection control market?
Why are services the fastest-growing type segment in the hospital acquired infection control market?
Why does North America lead the hospital acquired infection control market?
What is accelerating hospital acquired infection control market growth in Asia Pacific?
What are the prominent companies operating in the hospital acquired infection control landscape?
Our Clients
"The team took the time to understand our specific business needs and delivered a report that was well aligned with our objectives. Their expertise and understanding of the industry were clearly reflected in the quality and relevance of the insights provided."
Siemens Healthcare
"Our experience in acquiring the research report has been excellent. The depth of analysis, and actionable insights provided have been extremely valuable in supporting our ongoing R&D efforts."
GC Biopharma
"The report offered a comprehensive view of the market trends. The in-depth segmentation and analysis of emerging opportunities gave us a better understanding of the market."
Medtronic
Our Research Team & Methodology
Every Fundamental Business Insights report is built by a dedicated vertical research team, validated through a structured primary-and-secondary methodology, and reviewed for accuracy before it reaches you.
Research Team Overview
Prepared by the Healthcare & Medical Devices Research Team
Delivery
Published
Demand
Available
Support
Trust & Compliance
Research Domains
10 coverage areasResearch Intelligence
| Source | Reference |
|---|---|
| World Health Organization (WHO) | www.who.int |
| U.S. Food & Drug Administration (FDA) | www.fda.gov |
| European Medicines Agency (EMA) | www.ema.europa.eu |
| Centers for Disease Control and Prevention (CDC) | www.cdc.gov |
| National Institutes of Health (NIH) | www.nih.gov |
| National Center for Biotechnology Information (NCBI) | www.ncbi.nlm.nih.gov |
| PubMed | pubmed.ncbi.nlm.nih.gov |
| ClinicalTrials.gov | clinicaltrials.gov |
| International Organization for Standardization (ISO) | www.iso.org |
| ASTM International | www.astm.org |
| Advanced Medical Technology Association (AdvaMed) | www.advamed.org |
| Medical Device Innovation Consortium (MDIC) | mdic.org |
| Biotechnology Innovation Organization (BIO) | www.bio.org |
| International Federation of Pharmaceutical Manufacturers & Associations (IFPMA) | www.ifpma.org |
| U.S. Pharmacopeia (USP) | www.usp.org |
| European Directorate for the Quality of Medicines & HealthCare (EDQM) | www.edqm.eu |
| World Organisation for Animal Health (WOAH) | www.woah.org |
| American Hospital Association (AHA) | www.aha.org |
| OECD Health | www.oecd.org/health |
| World Bank Data | data.worldbank.org |
Research Workflow & Quality Assurance
Data Collection
Verified information gathered through primary and secondary research.
Data Triangulation
Cross-validation using multiple independent data sources.
Forecast Modelling
Market estimates developed using historical trends and analytical models.
Analyst Validation
Findings reviewed by domain experts for accuracy and consistency.
Editorial & Quality Review
Final editorial, quality, and compliance checks before publication.
Final Publication
Released after successful completion of the internal review process.
Report Coverage
📊 Market Assessment
- Market Size & Forecast
- Market Segmentation
- Regional Analysis
- Growth Drivers & Challenges
- Market Dynamics
🏢 Competitive Intelligence
- Competitive Landscape
- Company Profiles
- Competitive Benchmarking
- Mergers & Acquisitions
- Market Share Analysis or Key Company Strategies
🔍 Strategic Analysis
- Value Chain Analysis
- Porter's Five Forces
- PESTLE Analysis
- Pricing Trends
- Supply-Demand Analysis
🚀 Future Outlook
- Technology Landscape
- Regulatory Landscape
- Investment & Funding Landscape
- Emerging Opportunities
- Future Market Outlook
Have a question about this report or need a custom scope?
Request Customization